Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof

Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof

US Patent 11905332 · Granted Feb 20, 2024

Estimated economic value: $277,741,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies comprising chimeric constant domains2025
Heavy chain constant regions with reduced binding to Fc gamma receptors2025
Methods for treatment using chimeric antigen receptors specific for B-cell matur2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof2025
Chimeric antigen receptors specific for B-cell maturation antigen and encoding p2025
Non-human animals expressing humanized CD3 complex2025
Non-human animals expressing humanized CD3 complex2025
Antigen binding molecule formats2025
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD2025
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD2025